165 related articles for article (PubMed ID: 34559995)
1. A 584 bp deletion in CTRB2 inhibits chymotrypsin B2 activity and secretion and confers risk of pancreatic cancer.
Jermusyk A; Zhong J; Connelly KE; Gordon N; Perera S; Abdolalizadeh E; Zhang T; O'Brien A; Hoskins JW; Collins I; Eiser D; Yuan C; ; ; Risch HA; Jacobs EJ; Li D; Du M; Stolzenberg-Solomon RZ; Klein AP; Smith JP; Wolpin BM; Chanock SJ; Shi J; Petersen GM; Westlake CJ; Amundadottir LT
Am J Hum Genet; 2021 Oct; 108(10):1852-1865. PubMed ID: 34559995
[TBL] [Abstract][Full Text] [Related]
2. Sequencing of the complex CTRB1-CTRB2 locus in chronic pancreatitis.
Seltsam K; Pentner C; Weigl F; Sutedjo S; Zimmer C; Beer S; Bugert P; Ewers M; Ruffert C; Michl P; Laumen H; Witt H; Rosendahl J
Pancreatology; 2020 Dec; 20(8):1598-1603. PubMed ID: 33036922
[TBL] [Abstract][Full Text] [Related]
3. Smoking Modifies Pancreatic Cancer Risk Loci on 2q21.3.
Mocci E; Kundu P; Wheeler W; Arslan AA; Beane-Freeman LE; Bracci PM; Brennan P; Canzian F; Du M; Gallinger S; Giles GG; Goodman PJ; Kooperberg C; Le Marchand L; Neale RE; Shu XO; Visvanathan K; White E; Zheng W; Albanes D; Andreotti G; Babic A; Bamlet WR; Berndt SI; Blackford AL; Bueno-de-Mesquita B; Buring JE; Campa D; Chanock SJ; Childs EJ; Duell EJ; Fuchs CS; Gaziano JM; Giovannucci EL; Goggins MG; Hartge P; Hassan MM; Holly EA; Hoover RN; Hung RJ; Kurtz RC; Lee IM; Malats N; Milne RL; Ng K; Oberg AL; Panico S; Peters U; Porta M; Rabe KG; Riboli E; Rothman N; Scelo G; Sesso HD; Silverman DT; Stevens VL; Strobel O; Thompson IM; Tjonneland A; Trichopoulou A; Van Den Eeden SK; Wactawski-Wende J; Wentzensen N; Wilkens LR; Yu H; Yuan F; Zeleniuch-Jacquotte A; Amundadottir LT; Li D; Jacobs EJ; Petersen GM; Wolpin BM; Risch HA; Kraft P; Chatterjee N; Klein AP; Stolzenberg-Solomon R
Cancer Res; 2021 Jun; 81(11):3134-3143. PubMed ID: 33574088
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide association study identifies inversion in the
Rosendahl J; Kirsten H; Hegyi E; Kovacs P; Weiss FU; Laumen H; Lichtner P; Ruffert C; Chen JM; Masson E; Beer S; Zimmer C; Seltsam K; Algül H; Bühler F; Bruno MJ; Bugert P; Burkhardt R; Cavestro GM; Cichoz-Lach H; Farré A; Frank J; Gambaro G; Gimpfl S; Grallert H; Griesmann H; Grützmann R; Hellerbrand C; Hegyi P; Hollenbach M; Iordache S; Jurkowska G; Keim V; Kiefer F; Krug S; Landt O; Leo MD; Lerch MM; Lévy P; Löffler M; Löhr M; Ludwig M; Macek M; Malats N; Malecka-Panas E; Malerba G; Mann K; Mayerle J; Mohr S; Te Morsche RHM; Motyka M; Mueller S; Müller T; Nöthen MM; Pedrazzoli S; Pereira SP; Peters A; Pfützer R; Real FX; Rebours V; Ridinger M; Rietschel M; Rösmann E; Saftoiu A; Schneider A; Schulz HU; Soranzo N; Soyka M; Simon P; Skipworth J; Stickel F; Strauch K; Stumvoll M; Testoni PA; Tönjes A; Werner L; Werner J; Wodarz N; Ziegler M; Masamune A; Mössner J; Férec C; Michl P; P H Drenth J; Witt H; Scholz M; Sahin-Tóth M;
Gut; 2018 Oct; 67(10):1855-1863. PubMed ID: 28754779
[TBL] [Abstract][Full Text] [Related]
5. Arg236 in human chymotrypsin B2 (CTRB2) is a key determinant of high enzyme activity, trypsinogen degradation capacity, and protection against pancreatitis.
Németh BZ; Demcsák A; Micsonai A; Kiss B; Schlosser G; Geisz A; Hegyi E; Sahin-Tóth M; Pál G
Biochim Biophys Acta Proteins Proteom; 2022 Sep; 1870(9):140831. PubMed ID: 35934298
[TBL] [Abstract][Full Text] [Related]
6. Aberrant RNA Splicing Is a Primary Link between Genetic Variation and Pancreatic Cancer Risk.
Tian J; Chen C; Rao M; Zhang M; Lu Z; Cai Y; Ying P; Li B; Wang H; Wang L; Li Y; Huang J; Fan L; Cai X; Ning C; Li Y; Zhang F; Wang W; Jiang Y; Liu Y; Wang M; Li H; Huang C; Yang Z; Chang J; Zhu Y; Yang X; Miao X
Cancer Res; 2022 Jun; 82(11):2084-2096. PubMed ID: 35363263
[TBL] [Abstract][Full Text] [Related]
7. Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer.
Wolpin BM; Rizzato C; Kraft P; Kooperberg C; Petersen GM; Wang Z; Arslan AA; Beane-Freeman L; Bracci PM; Buring J; Canzian F; Duell EJ; Gallinger S; Giles GG; Goodman GE; Goodman PJ; Jacobs EJ; Kamineni A; Klein AP; Kolonel LN; Kulke MH; Li D; Malats N; Olson SH; Risch HA; Sesso HD; Visvanathan K; White E; Zheng W; Abnet CC; Albanes D; Andreotti G; Austin MA; Barfield R; Basso D; Berndt SI; Boutron-Ruault MC; Brotzman M; Büchler MW; Bueno-de-Mesquita HB; Bugert P; Burdette L; Campa D; Caporaso NE; Capurso G; Chung C; Cotterchio M; Costello E; Elena J; Funel N; Gaziano JM; Giese NA; Giovannucci EL; Goggins M; Gorman MJ; Gross M; Haiman CA; Hassan M; Helzlsouer KJ; Henderson BE; Holly EA; Hu N; Hunter DJ; Innocenti F; Jenab M; Kaaks R; Key TJ; Khaw KT; Klein EA; Kogevinas M; Krogh V; Kupcinskas J; Kurtz RC; LaCroix A; Landi MT; Landi S; Le Marchand L; Mambrini A; Mannisto S; Milne RL; Nakamura Y; Oberg AL; Owzar K; Patel AV; Peeters PH; Peters U; Pezzilli R; Piepoli A; Porta M; Real FX; Riboli E; Rothman N; Scarpa A; Shu XO; Silverman DT; Soucek P; Sund M; Talar-Wojnarowska R; Taylor PR; Theodoropoulos GE; Thornquist M; Tjønneland A; Tobias GS; Trichopoulos D; Vodicka P; Wactawski-Wende J; Wentzensen N; Wu C; Yu H; Yu K; Zeleniuch-Jacquotte A; Hoover R; Hartge P; Fuchs C; Chanock SJ; Stolzenberg-Solomon RS; Amundadottir LT
Nat Genet; 2014 Sep; 46(9):994-1000. PubMed ID: 25086665
[TBL] [Abstract][Full Text] [Related]
8. Associations between pancreatic expression quantitative traits and risk of pancreatic ductal adenocarcinoma.
Pistoni L; Gentiluomo M; Lu Y; López de Maturana E; Hlavac V; Vanella G; Darvasi E; Milanetto AC; Oliverius M; Vashist Y; Di Leo M; Mohelnikova-Duchonova B; Talar-Wojnarowska R; Gheorghe C; Petrone MC; Strobel O; Arcidiacono PG; Vodickova L; Szentesi A; Capurso G; Gajdán L; Malleo G; Theodoropoulos GE; Basso D; Soucek P; Brenner H; Lawlor RT; Morelli L; Ivanauskas A; ; Kauffmann EF; Macauda A; Gazouli M; Archibugi L; Nentwich M; Loveček M; Cavestro GM; Vodicka P; Landi S; Tavano F; Sperti C; Hackert T; Kupcinskas J; Pezzilli R; Andriulli A; Pollina L; Kreivenaite E; Gioffreda D; Jamroziak K; Hegyi P; Izbicki JR; Testoni SGG; Zuppardo RA; Bozzato D; Neoptolemos JP; Malats N; Canzian F; Campa D
Carcinogenesis; 2021 Aug; 42(8):1037-1045. PubMed ID: 34216462
[TBL] [Abstract][Full Text] [Related]
9. Associations between genetic variants of KIF5B, FMN1, and MGAT3 in the cadherin pathway and pancreatic cancer risk.
Zhao L; Liu H; Luo S; Moorman PG; Walsh KM; Li W; Wei Q
Cancer Med; 2020 Dec; 9(24):9620-9631. PubMed ID: 33200553
[TBL] [Abstract][Full Text] [Related]
10. Lack of replication of seven pancreatic cancer susceptibility loci identified in two Asian populations.
Campa D; Rizzato C; Bauer AS; Werner J; Capurso G; Costello E; Talar-Wojnarowska R; Jamroziak K; Pezzilli R; Gazouli M; Khaw KT; Key TJ; Bambi F; Mohelnikova-Duchonova B; Heller A; Landi S; Vodickova L; Theodoropoulos G; Bugert P; Vodicka P; Hoheisel JD; Delle Fave G; Neoptolemos JP; Soucek P; Büchler MW; Giese N; Canzian F
Cancer Epidemiol Biomarkers Prev; 2013 Feb; 22(2):320-3. PubMed ID: 23250936
[TBL] [Abstract][Full Text] [Related]
11. Integrative splicing-quantitative-trait-locus analysis reveals risk loci for non-small-cell lung cancer.
Wang Y; Ding Y; Liu S; Wang C; Zhang E; Chen C; Zhu M; Zhang J; Zhu C; Ji M; Dai J; Jin G; Hu Z; Shen H; Ma H
Am J Hum Genet; 2023 Sep; 110(9):1574-1589. PubMed ID: 37562399
[TBL] [Abstract][Full Text] [Related]
12. Re-evaluation of ABO gene polymorphisms detected in a genome-wide association study and risk of pancreatic ductal adenocarcinoma in a Chinese population.
Xu HL; Cheng JR; Zhang W; Wang J; Yu H; Ni QX; Risch HA; Gao YT
Chin J Cancer; 2014 Feb; 33(2):68-73. PubMed ID: 23816557
[TBL] [Abstract][Full Text] [Related]
13. Potential functional variants in SMC2 and TP53 in the AURORA pathway genes and risk of pancreatic cancer.
Feng Y; Liu H; Duan B; Liu Z; Abbruzzese J; Walsh KM; Zhang X; Wei Q
Carcinogenesis; 2019 Jun; 40(4):521-528. PubMed ID: 30794721
[TBL] [Abstract][Full Text] [Related]
14. The CTRB1/2 locus affects diabetes susceptibility and treatment via the incretin pathway.
't Hart LM; Fritsche A; Nijpels G; van Leeuwen N; Donnelly LA; Dekker JM; Alssema M; Fadista J; Carlotti F; Gjesing AP; Palmer CN; van Haeften TW; Herzberg-Schäfer SA; Simonis-Bik AM; Houwing-Duistermaat JJ; Helmer Q; Deelen J; Guigas B; Hansen T; Machicao F; Willemsen G; Heine RJ; Kramer MH; Holst JJ; de Koning EJ; Häring HU; Pedersen O; Groop L; de Geus EJ; Slagboom PE; Boomsma DI; Eekhoff EM; Pearson ER; Diamant M
Diabetes; 2013 Sep; 62(9):3275-81. PubMed ID: 23674605
[TBL] [Abstract][Full Text] [Related]
15. Endoplasmic stress-inducing variants in CPB1 and CPA1 and risk of pancreatic cancer: A case-control study and meta-analysis.
Kawamoto M; Kohi S; Abe T; Dbouk M; Macgregor-Das A; Koi C; Song KB; Borges M; Sugimine R; Laheru D; Hruban RH; Roberts N; Klein AP; Goggins M
Int J Cancer; 2022 Apr; 150(7):1123-1133. PubMed ID: 34817877
[TBL] [Abstract][Full Text] [Related]
16. A cross-tissue transcriptome-wide association study identifies novel susceptibility genes for lung cancer in Chinese populations.
Zhu M; Fan J; Zhang C; Xu J; Yin R; Zhang E; Wang Y; Ji M; Sun Q; Dai J; Jin G; Chen L; Xu L; Hu Z; Ma H; Shen H
Hum Mol Genet; 2021 Aug; 30(17):1666-1676. PubMed ID: 33909040
[TBL] [Abstract][Full Text] [Related]
17. Single nucleotide polymorphism in the microRNA-199a binding site of HIF1A gene is associated with pancreatic ductal adenocarcinoma risk and worse clinical outcomes.
Wang X; Ren H; Zhao T; Ma W; Dong J; Zhang S; Xin W; Yang S; Jia L; Hao J
Oncotarget; 2016 Mar; 7(12):13717-29. PubMed ID: 26872370
[TBL] [Abstract][Full Text] [Related]
18. CLK1/SRSF5 pathway induces aberrant exon skipping of METTL14 and Cyclin L2 and promotes growth and metastasis of pancreatic cancer.
Chen S; Yang C; Wang ZW; Hu JF; Pan JJ; Liao CY; Zhang JQ; Chen JZ; Huang Y; Huang L; Zhan Q; Tian YF; Shen BY; Wang YD
J Hematol Oncol; 2021 Apr; 14(1):60. PubMed ID: 33849617
[TBL] [Abstract][Full Text] [Related]
19. Functional characterization of a chr13q22.1 pancreatic cancer risk locus reveals long-range interaction and allele-specific effects on DIS3 expression.
Hoskins JW; Ibrahim A; Emmanuel MA; Manmiller SM; Wu Y; O'Neill M; Jia J; Collins I; Zhang M; Thomas JV; Rost LM; Das S; Parikh H; Haake JM; Matters GL; Kurtz RC; Bamlet WR; Klein A; Stolzenberg-Solomon R; Wolpin BM; Yarden R; Wang Z; Smith J; Olson SH; Andresson T; Petersen GM; Amundadottir LT
Hum Mol Genet; 2016 Nov; 25(21):4726-4738. PubMed ID: 28172817
[TBL] [Abstract][Full Text] [Related]
20. Polymorphisms in transcription factor binding sites and enhancer regions and pancreatic ductal adenocarcinoma risk.
Ünal P; Lu Y; Bueno-de-Mesquita B; van Eijck CHJ; Talar-Wojnarowska R; Szentesi A; Gazouli M; Kreivenaite E; Tavano F; Małecka-Wojciesko E; Erőss B; Oliverius M; Bunduc S; Nóbrega Aoki M; Vodickova L; Boggi U; Giaccherini M; Kondrackiene J; Chammas R; Palmieri O; Theodoropoulos GE; Bijlsma MF; Basso D; Mohelnikova-Duchonova B; Soucek P; Izbicki JR; Kiudelis V; Vanella G; Arcidiacono PG; Włodarczyk B; Hackert T; Schöttker B; Uzunoglu FG; Bambi F; Goetz M; Hlavac V; Brenner H; Perri F; Carrara S; Landi S; Hegyi P; Dijk F; Maiello E; Capretti G; Testoni SGG; Petrone MC; Stocker H; Ermini S; Archibugi L; Gentiluomo M; Cavestro GM; Pezzilli R; Di Franco G; Milanetto AC; Sperti C; Neoptolemos JP; Morelli L; Vokacova K; Pasquali C; Lawlor RT; Bazzocchi F; Kupcinskas J; Capurso G; Campa D; Canzian F
Hum Genomics; 2024 Feb; 18(1):12. PubMed ID: 38308339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
